
· Executive Brief
Newborn Screening Awareness Month 2026
Move from recognition activity to a visible operating route with named owners and closed loops.

Leadership signal
Use Newborn Screening Awareness Month to examine the system behind the message.
Leaders can use this window to test whether public information, service entry points, internal referrals, and follow-up responsibilities form one understandable route. The review should start with the experience of people using the system and the teams responsible for receiving them.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Newborn screening is a time-critical service line
Newborn screening is often seen as a public health program run by state laboratories. For a health system, it is also a chain of hospital operations. The chain runs from specimen collection on the birth unit to courier transport, result reporting, family contact, confirmatory testing and treatment. When any link is slow, the infant pays for it.
Each link takes time, and some conditions leave little room. For infantile Krabbe disease, stem cell transplant is preferably done by 30 days of age.[1] In one laboratory review, transplant occurred by the 36th day of life, on average, for cases detected by two-tier screening.[1] Even a strong process can miss a narrow clinical window.
Delays are common across conditions. In a Texas cystic fibrosis cohort of 247 people, the median age at first cystic fibrosis event was 29 days.[2] The authors described most people as having a delayed first event, possibly related to the timing of the second screen.[2] Infants with very delayed first events also had lower weight-for-age scores.[2]
Specimen quality is the first point where hospitals can act. In one well-baby nursery, 35% of specimens were unsatisfactory before a quality improvement project.[5] Every unsatisfactory specimen means a repeat collection and a later answer for the family.
This brief adds the research base to the executive guidance already on this page. It covers specimen quality, laboratory timeliness, follow-up and data, equity, parent communication and the workforce that runs the system. The focus is on operations that birth hospitals and health systems control. Each section notes where the evidence is limited or comes from outside the United States.
Current evidence
What the research says about quality, timeliness and follow-up
Focused quality work can transform specimen performance. The nursery project established a dedicated specimen collection team, staff education and review before dispatch.[5] During the intervention period of 2,395 specimens, the unsatisfactory rate fell to 5.3%.[5] The improvement was sustained for 18 months across 3,668 specimens.[5] Specimens obtained more than 48 hours after birth fell from 6.5% to 4.7%, so quality improved without slowing timeliness.[5]
Screening adoption improves detection timing at the population level. As U.S. states adopted spinal muscular atrophy screening, the proportion of infants with the condition detected by one month of age rose from 18% in 2017 to 61% in 2021.[3] By the end of 2022, 48 states were screening for the condition.[3] Infants with codes first recorded by one month rose from 1.3 per 100,000 for 2017 births.[3] The figure reached 6.6 per 100,000 among publicly insured newborns born in 2022.[3] The analysis used insurance claims, so it measures recorded diagnoses rather than clinical events directly.[3]
Pilot programs show what timely operations can look like. A statewide pilot in São Paulo screened 194,714 newborns for spinal muscular atrophy and found 14 positive cases.[4] First-tier results came at a median of 10.8 days of life, and treatment began at a median of 28 days.[4] About half of infants with two gene copies were already symptomatic at first evaluation, which shows how much speed matters.[4] Screening achieved 100% specificity in that pilot.[4]
Test design affects downstream timeliness. In the Texas cohort, sensitivity for cystic fibrosis was 90.9%, with 35 false negatives among 384 people.[2] The share with a first event by 28 days improved from 35% to 54% after the variant panel was expanded.[2] People with two variants identified had a median first event at 27 days, compared with 47.5 days for those with no variants identified.[2] Detection timing therefore depends on laboratory design choices that most hospital leaders never see.
Second-tier testing can shorten the path to diagnosis. Infants whose Krabbe screen included second-tier analysis received their diagnosis 7 days sooner, on average, than those whose testing began at follow-up.[1] The authors noted that this approach virtually eliminated false-positive results and that timeliness metrics need adjustment.[1] For executives, the lesson is to ask which timeliness metrics the state program uses and whether they match treatment windows.
Figure 1
Screening operations improve when someone owns the step
Percent of specimens or infants meeting each measure, before and after a change, as reported in each study. Values are copied from the cited studies [3], [5], [6]; none is estimated.
Data note. Each before-and-after pair comes from one study; comparisons across pairs are an indirect comparison because conditions, settings and measures differ.
Limitation. The hearing study changed its protocol alongside the database, and the national figures come from claims rather than clinical records.
Figure data (6 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Unsatisfactory specimens before a dedicated collection team | 35% | One well-baby nursery, baseline rate | [5] |
| Unsatisfactory specimens with a dedicated collection team | 5.3% | Same nursery, intervention period, 2,395 specimens | [5] |
| Diagnostic hearing test within 3 months, before a screening database | 7.41% | One Thai hospital, July 2022 to June 2023 | [6] |
| Diagnostic hearing test within 3 months, after a screening database | 52.63% | Same hospital, July 2023 to June 2024; 8,290 newborns across both periods | [6] |
| Spinal muscular atrophy detected by 1 month, 2017 | 18% | U.S. insurance claims, before most states screened | [3] |
| Spinal muscular atrophy detected by 1 month, 2021 | 61% | U.S. insurance claims, after broad state adoption | [3] |

Continuum of care
Where the screening chain breaks after the result
An abnormal result starts a second race. The infant must be located, the family contacted, a confirmatory test ordered and a specialist visit scheduled. Each step crosses an organizational boundary, and each boundary can add days. Executives rarely see this second race because it happens across phone calls, faxes and clinic schedules. A clear owner for each step, with a time target, turns that race into a managed process.
Follow-up practices vary widely even within one country. A national survey of 22 Italian metabolic centers found marked heterogeneity in managing biotinidase deficiency after an abnormal screen.[9] Centers reassessed enzyme activity using dried blood spots in 59.1%, plasma in 22.7% and serum in 18.2%.[9] Molecular testing occurred within 2 months at 40.9% of centers and after more than 5 months at 18.2%.[9] Treatment dosing and follow-up intensity also differed between centers, and partial deficiency was managed with particular variability.[9]
Referral rules can either reduce or add workload. A multicenter study followed 18 newborns with isolated low results on a screen for B-cell lymphopenia.[8] At first evaluation, at a mean age of 13.5 days, repeat dried blood spot testing already showed values above the cutoff in 78%.[8] All infants normalized by a mean age of 50 days.[8] No infectious or immunological complications occurred over 39.5 person-years of follow-up.[8] The authors suggested a repeat test before referral as a pragmatic triage step.[8]
Data systems hold the continuum together. A Thai hospital introduced a dedicated newborn hearing screening database and compared outcomes before and after across 8,290 newborns.[6] Screening coverage before one month rose from 83.47% to 96.64%, and referral rates fell from 18.44% to 6.47%.[6] Completion of diagnostic hearing tests within three months rose from 7.41% to 52.63%.[6] The study period also included adaptations to the screening algorithm, so the database was not the only change.[6]
The same study found that challenges persisted. Data remained incomplete, connections with other health information systems were limited, and caregiver-related barriers affected follow-up.[6] Completion within six months rose from 59.26% to 84.21%, but that change was not statistically significant.[6] A database can make gaps visible, but it does not close them without people assigned to act. Low hearing-aid uptake also persisted after diagnosis.[6] Follow-up ends at treatment, not at the diagnostic test.
Figure 3
Why the pathway breaks
People
- Specimen collection spread across untrained staff
- Clinicians unsure how to explain a positive screen
- No named coordinator for follow-up
Process
- Second specimens not scheduled before discharge
- Confirmatory testing timing varies by center
- Referral without repeat testing for likely transient results
Technology
- Limited variant panels miss some infants
- Screening databases not connected to other systems
- Incomplete data fields for follow-up
Environment
- Immigrant and refugee families reached late
- Misinformation on social media
- Distance and caregiver barriers to follow-up visits
Policy
- Algorithms that require two specimens
- No harmonized follow-up recommendations
- Coverage measured only for reporting laboratories
Measurement
- Timeliness metrics not matched to treatment windows
- Collection age not stratified by family background
- Follow-up completion not tracked after referral
Unranked qualitative cause-and-effect diagram for the outcome in the box: Screened newborns reach diagnosis and treatment later than their condition allows Causes are assembled from the cited literature [5], [10], [9], [8], [2], [6], [7], [14], [1], [15]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Specimen collection spread across untrained staff; Clinicians unsure how to explain a positive screen; No named coordinator for follow-up |
| Process | Second specimens not scheduled before discharge; Confirmatory testing timing varies by center; Referral without repeat testing for likely transient results |
| Technology | Limited variant panels miss some infants; Screening databases not connected to other systems; Incomplete data fields for follow-up |
| Environment | Immigrant and refugee families reached late; Misinformation on social media; Distance and caregiver barriers to follow-up visits |
| Policy | Algorithms that require two specimens; No harmonized follow-up recommendations; Coverage measured only for reporting laboratories |
| Measurement | Timeliness metrics not matched to treatment windows; Collection age not stratified by family background; Follow-up completion not tracked after referral |
Access
Making screening and follow-up reachable for every newborn
Access in newborn screening means that every infant is screened on time and every abnormal result reaches a family who can act on it. Coverage gaps and late collection undermine the rest of the system. Both depend on hospital routines at birth and discharge as much as on the state laboratory. Access also includes the family’s ability to understand why the test matters.
National coverage can fall short even where screening is established. A Colombian repository analyzed 243,536 records of births from January to September 2024.[15] Screening coverage, calculated from reporting laboratories, was 72.2% nationwide.[15] The average time from birth to result release was 4.8 days, and only 62.1% of results were issued within three days.[15] Strengthening the quality and timeliness of reporting was the authors’ main recommendation.[15] Coverage measured only through reporting laboratories can also overstate what a system knows.
Late collection is an access problem, not only a laboratory problem. In an Istanbul district with many refugees, 868 of 5,934 screened newborns were immigrants or refugees.[7] The median age at specimen collection was 12 days for immigrant and refugee newborns and 6 days for the local population.[7] Being an immigrant was an independent risk factor for delayed sampling regardless of primary care registration.[7] Because registration did not remove the gap, the fix must start earlier, at the birth hospital.
Once samples were collected, the system worked equally well. Transfer and approval times were identical for both groups, and recall rates were 0.4% in each.[7] Analytical performance was also comparable, with second-tier testing rates of 1.76% and 1.8%.[7] The authors concluded that the critical delay was in the initial access step.[7] They recommended targeted measures, including multilingual education at hospital discharge.[7] Hospitals that serve large immigrant communities can test the same pattern in their own data.
Second screens create a further access burden. In the Texas cystic fibrosis cohort, the authors suggested that delayed first events were possibly related to the timing of the second screen.[2] Health systems in states that require repeat specimens should make that second collection easy to complete. Scheduling it before discharge, offering it at the first newborn visit and tracking completion are operational choices within a hospital’s control. Text reminders and interpreter-supported calls can help families who move or change numbers after birth.
Executive guidance · System route
Connect the month to an accountable system route.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Listen
- Clarify entry
- Include the family route
- Protect transitions
- Verify and learn
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Listen
Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entry
Publish a plain-language first step and identify who receives requests through each approved channel.
Include the family route
Use locally approved methods to include the patient, family, or authorized caregiver as appropriate while keeping role, privacy, and next-step ownership clear.
Protect transitions
Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learn
Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Listen | Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions. |
| Clarify entry | Publish a plain-language first step and identify who receives requests through each approved channel. |
| Include the family route | Use locally approved methods to include the patient, family, or authorized caregiver as appropriate while keeping role, privacy, and next-step ownership clear. |
| Protect transitions | Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations. |
| Verify and learn | Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals. |
Equity and trust
Equity gaps appear at the first step and in the variants tested
Newborn screening is designed to be universal, but its operations are not equally reliable for every family. Equity review should examine who is screened late, whose results are less informative and whose families receive less information. It should also examine whether test design itself works equally well for different ancestries. Each of these can be measured locally.
Timing gaps can be large. Collection ages ranged from 0 to 176 days for local newborns and from 1 to 65 days for immigrant and refugee newborns.[7] The difference in medians, 12 days versus 6 days, matters for conditions that can cause crises in the first weeks.[7] The authors warned that this delay risks missing early diagnosis of salt-wasting congenital adrenal hyperplasia.[7] Discharge teaching in the family’s language is a practical first response.
Test panels can also carry inequity. In Texas, detection of two variants improved from 65.64% to 72.46% after the cystic fibrosis variant panel was expanded.[2] People with only one or no variants identified experienced greater delays, which the authors said highlights concerns about limited variant panels.[2] A limited panel can leave some infants with less informative results. Health systems can ask their state programs how panels are chosen and reviewed.
Information gaps follow language and education. In a Swedish survey of parents of young children, 98% knew that hearing loss affects language development, but only 56% recalled receiving information about early detection during newborn screening.[11] Most parents (70%) believed a child could still have hearing loss after passing the screen.[11] That belief was less common among parents with lower education or who did not speak Swedish at home.[11] Parents also often underestimated the ages at which children reach communication milestones.[11] Information given in the newborn period should therefore be repeated later.
Trust shapes participation as well. A content analysis of 260 social media posts opposing heel-prick screening in Türkiye identified themes of mistrust in medical science, alternative beliefs, conspiracy theories and solidarity among parents.[14] Misconceptions in the posts ranged from fabricated illnesses to claimed harms to babies’ energy.[14] The authors recommended improving digital health literacy and engaging health professionals on social media.[14] Equity work therefore includes listening to communities that doubt the program. Listening sessions with parents can reveal concerns before they spread online.

Human infrastructure
The people who make screening reliable
Newborn screening depends on nurses who collect specimens, couriers who move them, laboratory scientists who run tests, coordinators who track results and clinicians who talk with families. Each role is small within its department, which is why it can be overlooked. Each also changes with staffing, shift patterns and turnover.
Dedicated collection roles work. In the nursery project, the dedicated specimen collection team collected all specimens during the intervention.[5] The authors concluded that collection by trained staff with review before dispatch can improve quality without harming timeliness.[5] That finding argues for assigning the task to a small trained group rather than spreading it across every shift. Late specimens fell at the same time, which suggests the team did not slow collection.[5] Ownership also made performance visible, because one team could see and act on its own rate.
Clinician knowledge is a frequent weak point. Korean mothers whose infants screened positive described insufficient knowledge among health professionals, ineffective communication and inadequate guidance in scheduling confirmatory tests.[10] The study, based on interviews with 10 mothers, recommended professional training and parent-facing resources.[10] Mothers described emotional reactions ranging from not too concerned to very anxious.[10] Training should cover both the science of the screen and the logistics of the next step. Brief refresher sessions for nursery and pediatric staff can keep that knowledge current.
Follow-up roles need standard practice. The Italian survey of 22 centers found variability in treatment regimens, follow-up intensity and diagnostic re-evaluation, especially for partial deficiency.[9] The authors called for harmonized, evidence-based recommendations.[9] Inside a health system, a shared protocol and a named coordinator can reduce the same kind of variation. Harmonization also makes training simpler, because staff learn one pathway rather than several.
Laboratory and data staff also need tools. The Thai hearing program found that its database improved workflow coordination, but incomplete data and limited interoperability persisted.[6] The authors identified interoperability and staff training as keys to sustainable implementation.[6] Executives can fund both, and can include screening coordinators in information technology planning rather than adding their needs later. Screening coordinators often hold the only complete view of pending cases, so their workload and backup coverage deserve attention. Succession planning for these roles prevents a single absence from stalling follow-up.
Executive guidance · Operating dashboard
Review reliability, not campaign activity alone.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Entry-point clarity
Can people and staff identify the approved first step without searching across conflicting instructions?
- Candidate local measure
- Locally defined contact, routing, and repeat-contact signals by channel and service.
Executive guidance · Signal
Ownership reliability
Does a specific team accept each request and make its status visible?
- Candidate local measure
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
Executive guidance · Signal
Family-centered usability
Can patients, families, or authorized caregivers understand the entry point, responsible team, and next step where appropriate?
- Candidate local measure
- Locally defined communication barriers, repeated contacts, support requests, unresolved handoffs, and experience feedback.
Executive guidance · Signal
Improvement closure
Does the organization correct recurring friction and report what changed?
- Candidate local measure
- Selected barriers, assigned actions, completion status, and post-change review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Entry-point clarity | Executive sponsor and operational lead |
| Ownership reliability | Operational owner and participating teams |
| Family-centered usability | Sending and receiving owners |
| Improvement closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Transfer responsibility with acknowledgment and visibility.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Confirm the approved communication route for the patient, family, or authorized caregiver as locally appropriate.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Connect operating signals to accountable executive review.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Entry-point clarity | Can people and staff identify the approved first step without searching across conflicting instructions? | Executive sponsor and operational lead | At campaign launch and close |
| Ownership reliability | Does a specific team accept each request and make its status visible? | Operational owner and participating teams | At a locally defined cadence |
| Family-centered usability | Can patients, families, or authorized caregivers understand the entry point, responsible team, and next step where appropriate? | Sending and receiving owners | At a locally defined cadence |
| Improvement closure | Does the organization correct recurring friction and report what changed? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable newborn screening chain
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Dedicated, trained specimen collection with review before dispatch | Unsatisfactory specimens require repeat collection | Nurse manager of the newborn nursery | Unsatisfactory specimen rate by unit |
| Collection timing monitored against the target window | Late specimens delay results for time-critical conditions | Women and infants service line director | Share of specimens collected on time, stratified by family background |
| Second specimen scheduled before discharge where required | Families miss the repeat collection | Discharge planning lead and newborn clinic manager | Completion rate for required second specimens |
| Named follow-up coordinator for abnormal results | Infants are lost between result and confirmatory test | Newborn screening coordinator | Median days from abnormal result to confirmatory test and specialist visit |
| Shared protocol for confirmatory testing and referral | Variation in timing and unnecessary evaluations | Medical director for genetics or metabolic care | Adherence to the agreed protocol |
| Trained communication of positive screens with written materials | Parents leave confused and distressed | Patient and family experience leader | Share of families receiving scripted contact and materials in their language |
| Connected screening data system | Gaps in follow-up remain invisible | Chief information officer with laboratory leadership | Completeness of follow-up fields and interface status |
Control points derived from the cited evidence [5], [7], [2], [9], [8], [10], [6] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Communicating results in ways families can absorb
A positive screen is not a diagnosis, yet families often hear it as one. The way results are communicated shapes distress, trust and whether families complete confirmatory testing. Communication is therefore part of the clinical pathway, not an afterthought. It is also the moment when families first meet the specialty team.
Parents and clinicians often see severity differently. A study of 171 mothers and 168 fathers found that 61.9% of parents rated their child’s condition as more severe than the clinician did.[12] Higher parental severity ratings relative to clinicians were associated with higher distress and post-traumatic symptoms at baseline.[12] No differences remained at six months.[12] Parents completed validated measures of distress and post-traumatic symptoms.[12]
Each parent’s view also affects the other. In 115 couples, higher perceived severity in one parent was associated with lower perceived control in the partner.[12] Communication plans can therefore address both parents and invite questions from each. The authors suggested that psychosocial support may benefit from this dyadic perspective.[12] Offering a follow-up call after the first conversation gives each parent another chance to ask.
The effect extends beyond the couple. A review of 25 qualitative papers found that every initial positive screen, regardless of diagnosis, had consequences for wider family support.[13] Some parents became the medical expert for other relatives, some families grew more distant and some parents questioned whether to have more children.[13] Others experienced stronger support when relatives offered timely reassurance.[13] The authors described whether the impact is positive or negative as complex.[13]
Health systems can respond with clear scripts, trained communicators and written materials in the languages families speak. Materials should be tested with parents before use, including parents who speak languages other than English and those with limited health literacy. The Korean mothers asked for timely, clear and reliable information and practical guidance on the next appointment.[10] Public messages during the observance can explain what screening is, why a second specimen may be needed and what a positive screen does and does not mean. That clarity also counters misinformation, which spreads fastest where official information is thin. Families should also know who will call them, when and what to do if no one does. Leaders can review complaints and missed confirmatory appointments together to find where communication fails.

Executive guidance · 90-day plan
Use 90 days to correct one visible operating barrier.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how Newborn Screening Awareness Month communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Validate one access or transition route with patients, families, or authorized caregivers as locally appropriate.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how Newborn Screening Awareness Month communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Validate one access or transition route with patients, families, or authorized caregivers as locally appropriate. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Pair recognition with a system people can trust.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Connect the message to one usable, measured, and sustained operating change.
Executive action kit · Month observance
Turn Newborn Screening Awareness Month into accountable action.
Move from recognition activity to a visible operating route with named owners and closed loops.
Leadership focus
Use this observance to examine trustworthy information, prevention access, and community connection. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the family-centered information, access, coordination, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review caregiver language, disability access, transportation, digital access, school coordination, and differences in the ability to navigate the approved route.
Five-minute briefing
Inspect the operating sequence
Listen with children, families, pediatric teams, schools, community partners, and operational leaders. Find one a confusing entry point, an unacknowledged family concern, or a transition without a named owner, then test the locally approved route from entry through acknowledged follow-through.
- Listen
- Clarify entry
- Include the family route
- Protect transitions
- Verify and learn
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined contact, routing, and repeat-contact signals by channel and service.
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
- Locally defined communication barriers, repeated contacts, support requests, unresolved handoffs, and experience feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Public Health and Community Partners
Staff communication template
During Newborn Screening Awareness Month, our organization will connect awareness with a practical review of the family-centered information, access, coordination, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
Newborn Screening Awareness Month is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Hall PL, White AL, Peck D, Pino G, Studinski A, Gavrilov D, et al. Two-tiered newborn screening for infantile Krabbe disease allows timely treatment initiation and avoids false-positive results. Genetics in Medicine. 2026;28(4):101572. https://doi.org/10.1016/j.gim.2025.101572
- 2.Pottorff A, Knight S, Cannon CL, Lee M, Ren CL, Ruiz F, et al. Timeliness to diagnostic and early care milestones after newborn screening for Cystic Fibrosis in Texas: 14 years of experience at 2 centers. Journal of Cystic Fibrosis. 2026. https://doi.org/10.1016/j.jcf.2026.09.013
- 3.Grosse SD, Hong K, Yazdanpanah GK, Nash A, Gaviglio A, Gaffney M, et al. Trends in the Timeliness of Spinal Muscular Atrophy Detection in US Infants, 2016-2023. International Journal of Neonatal Screening. 2026;12(1). https://doi.org/10.3390/ijns12010009
- 4.Nani D, Mendonça RH, da Graça FF, Pinheiro VRP, Carneireiro M, Farah BG, et al. Expanding 5q-SMA Newborn Screening in Latin America: A Brazilian Model for National and Regional Implementation. International Journal of Neonatal Screening. 2026;12(3). https://doi.org/10.3390/ijns12030050
- 5.Shrestha D, Ikeri K, Curtis V, Williams K, Humphries V, Zayek M. Improving the quality of newborn screening dry blood spot specimens in the nursery. Journal of Perinatology. 2026. https://doi.org/10.1038/s41372-026-02793-9
- 6.Parangrit K, Sillabutra J, Isaradisaikul SK, Kulprachakarn K. Implementation and Evaluation of a Newborn Hearing Screening Database in a Resource-Limited Setting: Advantages and Limitations. Children. 2026;13(1):22. https://doi.org/10.3390/children13010022
- 7.Arslan E, Sezerol MA. Disparities in Congenital Adrenal Hyperplasia Screening Follow-up Times Between Immigrants/Refugees and Local Populations in Türkiye: A Cross-Sectional Study. Turkish Archives of Pediatrics. 2026;61(8):696-702. https://doi.org/10.65717/turkarchpediatr.2026.25540
- 8.Valentina G, Enrico D, Caterina P, Silvia B, Francesca S, Monica T, et al. Transient B cell lymphopenia revealed by KRECs newborn screening: Post-screening referral strategies, clinical course, and follow-up. Pediatric Allergy and Immunology. 2026;37(7):e70421. https://doi.org/10.1111/pai.70421
- 9.Tagliaferri F, Candela E, Biasucci G, Bonati MT, Bordugo A, Concolino D, et al. Current management of biotinidase deficiency following newborn screening in Italy: evidence from a clinical nationwide survey. Molecular Genetics and Metabolism. 2026;149(3). https://doi.org/10.1016/j.ymgme.2026.110264
- 10.Yu KE, Kim JS. Mothers’ experiences of the communication of positive results on newborn screening for metabolic diseases: A qualitative content analysis. Journal of Pediatric Nursing. 2026;90:376-384. https://doi.org/10.1016/j.pedn.2026.06.033
- 11.Mackey AR, Löfkvist U. Parental awareness of childhood hearing loss, risk factors and communication milestones following newborn hearing screening. International Journal of Pediatric Otorhinolaryngology. 2026;208:112962. https://doi.org/10.1016/j.ijporl.2026.112962
- 12.Bani M, Russo S, Gasperini S, Crescitelli V, Menni F, Furlan F, et al. Perceived severity and parental distress after positive expanded newborn screening: parent-clinician concordance and dyadic processes. European Journal of Pediatrics. 2026;185(5). https://doi.org/10.1007/s00431-026-06983-7
- 13.Musa C, Ulph F. Exploring the impact on intrafamilial support systems when newborn screening programmes contact parents with an initial screen positive result. European Journal of Human Genetics. 2026. https://doi.org/10.1038/s41431-026-02128-4
- 14.Uçtu AK, Buyrukoğlu RC. Digital misinformation and parental resistance to newborn heel-prick screening: an Instagram content analysis. Scandinavian Journal of Clinical and Laboratory Investigation. 2026;86(5):463-470. https://doi.org/10.1080/00365513.2026.2692692
- 15.Hidalgo AM, Fuya OP, Martínez DP. Repositorio de tamizaje neonatal, una herramienta para la toma de decisiones en salud pública. Biomédica. 2025;45(4):599-611. https://doi.org/10.7705/biomedica.7819
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| Specimen quality improvement on the birth unit | [5] | 2026 | Current evidence | Single-nursery quality improvement project; results depend on local staffing and baseline performance. |
| Timeliness of detection after screening adoption | [3] [4] | 2026 | Current evidence | Claims-based national estimates and a single-state pilot; the 2022 U.S. figure was a projection and is not used here. |
| Test design, sensitivity and time to first event | [2] [1] | 2026 | Current evidence | Retrospective two-center and single-laboratory reviews; condition-specific findings. |
| Follow-up variation and referral triage | [9] [8] | 2026 | Continuum of care | Self-reported center survey and a small multicenter case series of 18 infants. |
| Data systems and follow-up completion | [6] [15] | 2026, 2025 | Continuum of care | Before-after study with concurrent protocol changes and a national repository limited to reporting laboratories. |
| Access and equity in collection timing | [7] | 2026 | Access | One district in one year; immigrant status recorded administratively. |
| Parent knowledge and trust | [11] [14] | 2026 | Equity and trust | Anonymous parent survey and a content analysis of social media posts; neither measures screening uptake directly. |
| Communication of positive results and family impact | [10] [12] [13] | 2026 | Public communication | Small qualitative sample, one cohort study of expanded screening and a narrative synthesis of qualitative papers. |

About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.

